Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Simon J Read & Andy Dray. (2008) Osteoarthritic pain: a review of current, theoretical and emerging therapeutics. Expert Opinion on Investigational Drugs 17:5, pages 619-640.
Read now
Read now
Eleni Dlcou, Patrick Vermersch, Isabelle Penisson-Besnier, Frederic Dubas & Veronique Nerriere. (1997) Anti-NGF Autoantibodies and NGF in Sera of Alzheimer Patients and in Normal Subjects in Relation to Age. Autoimmunity 26:3, pages 189-194.
Read now
Read now
Articles from other publishers (23)
Maurizio Cutolo & Amelia Chiara Trombetta. 2021. Endocrinology and Systemic Diseases. Endocrinology and Systemic Diseases
263
279
.
Maurizio Cutolo & Amelia Chiara Trombetta. 2019. Endocrinology and Systemic Diseases. Endocrinology and Systemic Diseases
1
17
.
Maurizio Cutolo & Amelia Chiara Trombetta. 2019. Mosaic of Autoimmunity. Mosaic of Autoimmunity
601
608
.
Benjamin Weinkauf, Saskia Deising, Otilia Obreja, Ulrich Hoheisel, Siegfried Mense, Martin Schmelz & Roman Rukwied. (2015) Comparison of nerve growth factor-induced sensitization pattern in lumbar and tibial muscle and fascia. Muscle & Nerve 52:2, pages 265-272.
Crossref
Crossref
Maria Osikowicz, Geraldine Longo, Simon Allard, A Claudio Cuello & Alfredo Ribeiro-da-Silva. (2013) Inhibition of Endogenous NGF Degradation Induces Mechanical Allodynia and Thermal Hyperalgesia in Rats. Molecular Pain 9, pages 1744-8069-9-37.
Crossref
Crossref
Otilia Obreja, Matthias Ringkamp, Brian Turnquist, Michael Hirth, Elmar Forsch, Roman Rukwied, Marlen Petersen & Martin Schmelz. (2011) Nerve growth factor selectively decreases activity-dependent conduction slowing in mechano-insensitive C-nociceptors. Pain 152:9, pages 2138-2146.
Crossref
Crossref
M. Isola, V. Ferrari, A. Miolo, F. Stabile, D. Bernardini, P. Carnier & R. Busetto. (2011) Nerve growth factor concentrations in the synovial fluid from healthy dogs and dogs with secondary osteoarthritis. Veterinary and Comparative Orthopaedics and Traumatology 24:4, pages 279-284.
Crossref
Crossref
Till A. Röhn, William T. Ralvenius, Jolly Paul, Petra Borter, Marcela Hernandez, Robert Witschi, Paula Grest, Hanns Ulrich Zeilhofer, Martin F. Bachmann & Gary T. Jennings. (2011) A Virus-Like Particle-Based Anti-Nerve Growth Factor Vaccine Reduces Inflammatory Hyperalgesia: Potential Long-Term Therapy for Chronic Pain. The Journal of Immunology 186:3, pages 1769-1780.
Crossref
Crossref
Matthias F. Seidel, Marjeta Herguijuela, Randolf Forkert & Uwe Otten. (2010) Nerve Growth Factor in Rheumatic Diseases. Seminars in Arthritis and Rheumatism 40:2, pages 109-126.
Crossref
Crossref
Adriana Pelegrini-da-Silva, Maria Cláudia G. Oliveira, Carlos Amílcar Parada & Cláudia Herrera Tambeli. (2008) Nerve growth factor acts with the β2-adrenoceptor to induce spontaneous nociceptive behavior during temporomandibular joint inflammatory hyperalgesia. Life Sciences 83:23-24, pages 780-785.
Crossref
Crossref
Andy Dray. (2008) New Horizons in Pharmacologic Treatment for Rheumatic Disease Pain. Rheumatic Disease Clinics of North America 34:2, pages 481-505.
Crossref
Crossref
Eleni Dicou. (2008) High levels of the proNGF peptides LIP1 and LIP2 in the serum and synovial fluid of rheumatoid arthritis patients: Evidence for two new cytokines. Journal of Neuroimmunology 194:1-2, pages 143-146.
Crossref
Crossref
O. Schulte-Herbrüggen, R. Fölster-Holst, M. von Elstermann, M. Augustin & R. Hellweg. (2007) Clinical Relevance of Nerve Growth Factor Serum Levels in Patients with Atopic Dermatitis and Psoriasis. International Archives of Allergy and Immunology 144:3, pages 211-216.
Crossref
Crossref
Janine Ezendam, Frank Staedtler, Jeroen Pennings, Rob J Vandebriel, Raymond Pieters, Paolo Boffetta, Johannes H Harleman & Joseph G Vos. (2004) Toxicogenomics of subchronic hexachlorobenzene exposure in Brown Norway rats.. Environmental Health Perspectives 112:7, pages 782-791.
Crossref
Crossref
Janine Ezendam, Frank Staedtler, Jeroen Pennings, Rob J. Vandebriel, Raymond Pieters, Johannes H. Harleman & Joseph G. Vos. (2004) TOXICOGENOMICS OF SUBCHRONIC HEXACHLOROBENZENE EXPOSURE IN BROWN NORWAY RATS. Environmental Health Perspectives.
Crossref
Crossref
Masamichi Shinoda, Takashi Honda, Noriyuki Ozaki, Hisashi Hattori, Hideki Mizutani, Minoru Ueda & Yasuo Sugiura. (2003) Nerve terminals extend into the temporomandibular joint of adjuvant arthritic rats. European Journal of Pain 7:6, pages 493-505.
Crossref
Crossref
K TITANJI, A NILSSON, C MÖRCH, A SAMUELSSON, A SÖNNERBORG, S GRUTZMEIER, M ZAZZI & A DE MILITO. (2003) Low frequency of plasma nerve-growth factor detection is associated with death of memory B lymphocytes in HIV-1 infection. Clinical and Experimental Immunology 132:2, pages 297-303.
Crossref
Crossref
Rainer HellwegRainer Hellweg. 2000. Der Nerve Growth Factor bei neuropsychiatrischen Erkrankungen. Der Nerve Growth Factor bei neuropsychiatrischen Erkrankungen
192
251
.
Beth Pflug & Daniel Djakiew. (1998) Expression of p75NTR in a human prostate epithelial tumor cell line reduces nerve growth factor–induced cell growth by activation of programmed cell death. Molecular Carcinogenesis 23:2, pages 106-114.
Crossref
Crossref
Heinrich P. Fischer, Wolfgang Eich & I. Jon Russell. (1998) A possible role for saliva as a diagnostic fluid in patients with chronic pain. Seminars in Arthritis and Rheumatism 27:6, pages 348-359.
Crossref
Crossref
Klaus Bendtzen, Morten B Hansen, Christian Ross & Morten Svenson. (1998) High-avidity autoantibodies to cytokines. Immunology Today 19:5, pages 209-211.
Crossref
Crossref
Yasuhiko SUSAKI, Akane TANAKA, Eiichi HONDA & Hiroshi MATSUDA. (1998) Nerve Growth Factor Modulates Fc Gamma Receptor Expression on Murine Macrophage J774A.1 Cells.. Journal of Veterinary Medical Science 60:1, pages 87-91.
Crossref
Crossref
E Dicou & V Nerrière. (1997) Evidence that natural autoantibodies against the nerve growth factor (NGF) may be potential carriers of NGF. Journal of Neuroimmunology 75:1-2, pages 200-203.
Crossref
Crossref